Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-29,300
Closed -$4.32M 1925
2020
Q1
$4.32M Buy
+29,300
New +$4.67M 0.05% 367
2018
Q3
Sell
-13,000
Closed -$1.35M 2696
2018
Q2
$1.35M Buy
+13,000
New +$1.32M 0.01% 1093
2016
Q4
Sell
-10,000
Closed -$648K 2433
2016
Q3
$648K Sell
10,000
-5,600
-36% -$373K ﹤0.01% 1502
2016
Q2
$986K Buy
+15,600
New +$920K ﹤0.01% 1156
2015
Q2
Sell
-3,900
Closed -$280K 3470
2015
Q1
$280K Sell
3,900
-17,700
-82% -$1.15M ﹤0.01% 1632
2014
Q4
$1.21M Sell
21,600
-26,100
-55% -$1.36M 0.01% 899
2014
Q3
$2.35M Buy
47,700
+26,100
+121% +$1.33M 0.02% 663
2014
Q2
$1.09M Buy
+21,600
New +$1.07M 0.01% 877

Other funds holding RMD

Jefferies Group's RMD Position: Q3 2022 in Review

Jefferies Group opened a new position in ResMed (RMD) in Q3 2022: 14,785 shares worth $3.23M. The stake represents 0.03% of the portfolio and ranks #459 among its holdings. This is a return to the name: Jefferies Group previously reported a position in RMD as recently as Q4 2020.

Jefferies Group first reported a position in RMD in Q2 2013 and has held it in 22 quarters since. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Jefferies Group held 14,785 shares of ResMed worth $3.23M as of Q3 2022.
  • ResMed was a new Jefferies Group position in Q3 2022.
  • ResMed made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #459 holding.
  • Jefferies Group first reported a position in ResMed in Q2 2013 and has held it in 22 quarters since.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.